Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-28

Clinical Trial Update: Evaluation of the RESTART Survival Programme

View source ↗

Summary

Clinical trial update on the RESTART Survival Programme, sponsored by Jules Bordet Institute, evaluating treatment for invasive breast cancer; the study is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Jules Bordet Institute | Conditions: Invasive Breast Cancer | Status: NOT_YET_RECRUITING